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In the past years, the co-existence of depressive disorders/symptoms with HIV infection has been 
well documented in the literature. However, factors that are associated with increased depressive 
disorders/symptoms among individuals living with HIV remain largely understudied. Therefore, 
this study aims to examine sociodemographic, behavioral and clinical risk factors that are 
associated with self-reported depressive symptoms in people living with HIV/AIDS (PLWHA) in 
Saskatoon. 
We used a cross sectional study of 351 PLWHA who were accessing care at the positive living 
program (PLP) unit of the Royal University Hospital (RUH) in Saskatoon from 2010 to 2015. 
Descriptive statistics were carried out to explore our data. Univariate analysis was performed using 
Pearson’s chi-square test and univariate/multivariable logistic regression models were used to 
examine the association between self-reported depressive symptoms and the variables being 
investigated. All variables were analyzed using SPSS version 21 and the significant level was P < 
0.05 throughout the analysis. 
Our study examined the medical chart records of 351 patients. 113 patients (32.2%) self-reported 
depressive symptoms at baseline, 18 (5.1%) denied depressive symptoms and 219 (62.6%) were 
missing depression information. From the 113 (32.2%) patients who self-reported depressive 
symptoms, 81 (71.7%) were above the age of 35 years, 68 (60.2%) male, 49 (43.4%) were from 
indigenous ancestry and 40 (35.4%) reported injection drug use (IDU). Their clinical/laboratory 
test reports indicated that 24 (21.2%) patients had low CD4+ cell counts (< 200 cells/μl), 49 






cell counts (>500 cells/μl), and 10 (8.8%) had non-detectable viral load. Our analysis showed that 
people from indigenous ancestry, employed, formal support, men who have sex with men 
(MSM)/homosexual men and prior history of incarceration were independently associated with 
self-reported depressive symptoms. However, MSM (P <0.04) and employed PLWHA (P <0.02) 
were associated with self-reported baseline depressive symptoms at the level of the multivariate 
logistic model. Based on the study findings, future social programs should pay closer attention to 
MSM/homosexual men and employed PLWHA to manage early signs and symptoms of depression 
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CHAPTER 1: NATURE AND PURPOSE OF THE STUDY 
INTRODUCTION 
Despite global efforts to reduce the spread of  human immunodeficiency virus (HIV), the infection 
continues to spread rapidly among the general population (World Health Organization, 2005). 
Although, rapid availability of treatment regimens have considerably reduced HIV burden, 
however, factors such as lack of coverage and access to prevention services as well as inadequate 
scientific evaluation programs have reduced desired outcomes (Bertozzi et al., 2006). 
People living with HIV/AIDS (PLWHA) are known to have high needs that may necessitate 
consistent support to cope with their disease status (Gerbi et al., 2012). Some of the potential 
feelings they face include shock of positive serology, fear of disease advancement, fear of being 
neglected by friends and relatives, worries about disease transmission and stress of keeping up 
with routine treatment (Gerbi et al., 2012). Aside psychological and physiology stressors that come 
with HIV infection, the disease is also highly stigmatized (Valdiserri, 2002; Link and Phelan, 2006; 
Wailoo, 2006). The accumulation of these stressors may result in potential mental disorders among  
infected individuals (Gerbi et al., 2012).  
Depression and HIV/AIDS are two chronic conditions that have posed challenges to public health 
practitioners and unfortunately, both illnesses are highly comorbid (Bing et al., 2001; Ciesla and 
Roberts, 2001; Simoni et al., 2011). Stressful daily living, adverse life events, side effects of 
medications and the neurological effects of HIV infection could trigger depressive symptoms 
among individuals living with HIV/AIDS and may rapidly advance HIV infection to AIDS 
(Leserman et al., 1997). Studies in Western countries estimated the prevalence of depressive 






(Ciesla and Roberts, 2001). The comorbidity of both illnesses can reduce patient adherence to HIV 
treatment  (Himelhoch et al., 2009; Sin and DiMatteo, 2013), lower their quality of life and 
increase morbidity and mortality rate amongst the sufferers (Andrinopoulos et al., 2011; Reis et 
al., 2011). 
Many studies have explored the association between depressive disorders/symptoms and HIV 
infection. However, the results from several studies are equivocal. For instance, some researchers 
found factors such as age ( Liu et al., 2014), ethnicity (Pellowski et al., 2013, gender (Stewart et 
al., 2011) and injection drug uses (Hammond et al., 2016) to be positively associated with 
depressive disorders/symptoms among PLWHA, while others found no association between those 
factors and depressive disorders/symptoms (Mohammed et al., 2015; Rai and Verma, 2015).  
Based on the equivocal findings from prior research and coupled with the fact that no study has 
examined factors associated with depressive disorders/symptoms among PLWHA in Saskatoon, it 
was imperative to carry out a study that examined the factors that are associated with self-reported 
depressive symptoms in individuals with HIV/AIDS. This thesis explored factors associated with 
self-reported depressive symptoms among PLWHA at the positive living program (PLP) unit of 
the Royal University Hospital (RUH) in Saskatoon from 2010 to 2015. The findings from this 
study will add to the body of evidence by providing valuable information and recommendations 
to policymakers, clinicians and end users on the management of depressive disorders/symptoms 
among individuals living with HIV/AIDS.  
RESEARCH QUESTIONS  
To achieve the purpose of our study, the following questions were investigated and answered. 
• What is the prevalence of self-reported depressive symptoms among PLWHA in Positive 






• Is there an association between socio-demographic factors and self-reported depressive 
symptoms among PLWHA in PLP? 
• Is there an association between behavioral variables and self-reported depressive 
symptoms among PLWHA in PLP?   
• Is there an association between clinical variables and self-reported depressive symptoms 
among PLWHA in PLP? 
MEASUREMENT OF STUDY VARIABLES  
The analysis in this study was achieved by systematically extracting data from patients’ medical 
records at the PLP of the RUH in Saskatoon. The outcome variable was self-reported depressive 
symptoms by the patients at their initial visit to PLP and recorded by the attending nurse. Other 
variables of interest such as socio-demographic, behavioral and clinical variables were obtained 
from the patients’ initial assessment forms, HIV case report forms and laboratory test reports in 
their medical charts. 
NATURE OF THE STUDY 
This is a cross sectional study of PLWHA at the PLP unit of the RUH. The outcome variable is 
self-reported depressive symptoms, and the independent variables are age, gender, ethnicity, 
marital status, social support, employment status, men who have sex with men (MSM), injection 
drug users (IDUs), substance use, viral load, CD4+ cells counts and liver enzymes function tests. 
For statistical purposes, the independent variables were categorized into socio-demographic 
variables (age, gender, ethnicity, marital status, social support, employment status), behavioral 
variables (MSM, IDU, incarceration, substance use and alcohol use) and clinical variables (viral 







We analyzed these variables independently and jointly to test the association between our 
independent variables on the outcome variable. Descriptive statistics were conducted to summarize 
the data. Univariate and multiple regression models were used to examine the association between 
the predictor variables and the outcome variable. All significant variables at P<0.05 in our 
univariate analysis were further considered for multivariable analysis. The significance level for 
multivariable analysis was set at P<0.05. Confounding and biologically plausible interactions were 







CHAPTER 2: LITERATURE REVIEW 
This section provides a brief introduction to HIV/AIDS infection and the magnitude of the 
problem, including the global, national and provincial epidemiology of HIV/AIDS. The section 
also gives a detailed description of depression and its comorbid effects on individuals living with 
HIV/AIDS infection. Factors identified in previous studies to be associated with depressive 
disorders/symptoms in people living with HIV/AIDS (PLWHA) are also presented. The 
conceptual framework that explained those factors predisposing PLWHA to depressive 
disorders/symptoms is discussed. The term diagnosed HIV infection meant the incidence of HIV 
infection as reported by many studies. 
OVERVIEW/ TRANSMISSION OF HIV 
Human immunodeficiency virus (HIV) is a group of retroviruses that cause acquired 
immunodeficiency syndrome (AIDS), a condition in which most of the body immune system are 
being destroyed making way for opportunistic infections to advance (Joint United Nations 
Programmes for HIV/AIDS, 2000). HIV infection is transmitted through sexual contacts, 
parenteral and perinatal transmission (Shaw and Hunter, 2012).  
HIV infection is commonly referred to as a sexually transmitted disease because it is contracted 
mostly through various sexual contacts with the bodily fluid of infected individuals (Galvin and 
Cohen, 2004; Klimas et al., 2008). Integrated approaches to risky behaviors and condom use are 
effective in decreasing the risk of HIV transmission through sexual contacts (Coates et al., 2008). 
Parenteral transmission includes unsafe blood transfusion, exposure to blood through exchange of 
contaminated needles/syringes and inadequate sterilization of instruments used in healthcare 
facilities (Baggaley et al., 2006). Preventive measures such as needle exchange programs, 






users (IDUs) are effective in reducing the spread of HIV through parenteral routes (Vlahov et al., 
2010). Perinatal disease transmission occur in utero, during conception or shortly after delivery 
(Ishrat et al., 2010; Siegfried et al., 2011). Chorioamnionitis, premature rupture of membranes and 
breastfeeding can increase perinatal transmission (Bhoopat et al., 2005; Ocheke et al., 2016).  
GLOBAL BURDEN OF HIV/AIDS 
A report from the WHO in 2008 showed that approximately 33.4 million people were living with 
HIV/AIDS worldwide (World Health Organization and UNAIDS, 2009). In 2016, 36.7 million 
people were reported to be living with HIV. In the same year, 1.8 million people were newly 
diagnosed and approximately 1 million people died due to HIV/AIDS complications (Joint United 
Nations Programme on HIV/AIDS, 2017). The epidemic of HIV/AIDS infection has severely 
affected most African countries particularly the sub-Saharan region. According to 2017 WHO 
report, about 25.7 million people were living with HIV/AIDS in sub-Saharan Africa, accounting 
for approximately 68% of global HIV burden in 2018 (World Health Organization, 2019).  
Asia and the Pacific regions recorded the second largest number of HIV infections worldwide. 
According to the Joint United Nations Programme for HIV/AIDS (UNAIDS) report in 2017, about 
5.1 million people had HIV infection and in 2016, approximately 270,000 new cases of HIV  were 
reported in Asia and Pacific regions (Joint United Nations Programme on HIV/AIDS, 2017). In 
the European region, about 159,000 people were newly diagnosed with HIV in 2017 (World Health 
Organization Regional Office in Europe, 2018a). The World Health Organization reported that 
almost 160,000 people were newly infected in Europe with the majority of cases (about 80%) 
occurring in the eastern parts of the continent (World Health Organization Regional Office in 






HIV IN NORTH AMERICA 
In 2016, North America and Western and Central Europe reported that 2.1 million adults and 
children were living with HIV.  In the same year, about 73,000 people were newly diagnosed with 
HIV and 18,000 people died due to AIDS-related complications (Joint United Nations Programme 
on HIV/AIDS (UNAIDS), 2017). In the United States, approximately 1.1 million people (13 years 
and older) were reported to have HIV infection (Centers for Disease Control and Prevention, 
2018). Populations most affected by the burden of HIV infection are men who have sex with men 
(MSM), African American/black men, Hispanic men and transgender women (Centers for Disease 
Control and Prevention, 2018). Rigorous HIV/sex education, condom use, awareness campaigns, 
efforts to reduce HIV infection via vertical transmission and harm reductions have been effective 
in reducing HIV transmission in the United States (Centers for Disease Control and Prevention, 
2015). 
HIV IN CANADA 
In 2016, 63,110 people were living with HIV infection in Canada (Public Health Agency of 
Canada, 2015, 2016). In 2017, 2,402 new cases of HIV infection were reported nationally, this 
shows an increase of 3% and 17.1% in the numbers of newly reported HIV infection in 2016 and 
2014 respectively (Public Health Agency of Canada, 2017). Also, the national diagnosis rate 
showed an increase from 5.8 per 100,000 population in 2014 to 6.5 per 100,000 population in 2017 









Figure 2.1: Number of reported cases, including national, male and female diagnostic rates, by 
year of test— Canada, 1996–2017 
 
Source: HIV in Canada – Surveillance Report, 2017 (Public Health Agency of Canada, 2017: 
p326). 
 
Nationally, the distribution of diagnosed HIV infection by age between 2013 to 2017 showed that 
30 – 39 age group reported the highest rate of HIV infection (14.8 per 100,000 population). 
Children less than 15 years had the least average rate within the 5 years period (Public Health 

















Figure 2.2: HIV Diagnosis rate, by age group and year of test—Canada, 2013–2017 
 
Source: HIV in Canada – Surveillance Report, 2017 (Public Health Agency of Canada, 2017: 
p327). 
 
By exposure category, high risk individuals are often over represented among the newly diagnosed 
cases across Canada  (Moraros et al., 2011; Bird et al., 2016). From PHAC 2016 surveillance 
report, 2,165 were newly diagnosed with HIV, of which  52.5% (1,136) were observed among 
MSM and bisexual men, 11.3% (244) among IDUs, and 33% (744) from various heterosexual 
contacts (Public Health Agency of Canada, 2016). Similarly, in 2017,  2,402 newly diagnosed HIV 
were reported (>15 years), approximately 46.5% (1,115) were reported among gay, bisexual, and 
other men who have sex with men and 16.3% (392) among IDUs (Public Health Agency of 
Canada, 2017). Also, indigenous people and immigrants from endemic nations are over-
represented in the epidemic of newly diagnosed HIV infection in Canada. For example, from the 
2,165 new cases in 2016, 11.3% (245) were observed among indigenous people and 13.6% (294) 






HIV IN SASKATCHEWAN 
Diagnosed HIV infection rates have considerably declined within the last few decades due to 
rigorous efforts in the management and treatment of HIV/AIDS across Canada (Rogers et al., 
2015). However, Saskatchewan still battles with the increase in the reported incidence rate of HIV 
infections (Rogers et al., 2015; Vogel, 2015). For example, Saskatchewan showed an increase in 
the reported incidence rate of HIV infection from 3.3 per 100,000 in 2002 to 20.8 per 100,000 in 
2008 (Public Health Agency of Canada, 2014), reaching its peak of 193 per 100,000 in 2009 
(Saskatchewan Ministry of Health, 2017). In 2016, the reported incidence rate of HIV infection in 
Saskatchewan was 14.5 per 100,000, a rate that is approximately 2.3 times higher than the national 
average of 6.4 per 100,000 (Saskatchewan Ministry of Health, 2016). Refer to figure 2.3 for 
additional information. 
Figure 2.3: HIV diagnosis rates, Saskatchewan versus Canada from 2008 to 2017. 
  







HIV IN SASKATOON 
Data specific for Saskatoon is not generally available, therefore, data from SHR will be used unless 
stated otherwise. In 2004, the Saskatoon Health Region (SHR) reported 16 new cases of HIV but 
39 in 2005, 53 in 2006, 57 in 2007, 77 in 2008 and 94 in 2009 (Lemstra et al, 2011).  In 2012, SHR 
reported an annual incidence rate of 17.0 per 100, 000 individuals, a rate which almost triple that 
of the national average of 5.9 per 100, 000 in 2012 (Saskatoon Health Region, 2015).  
The increasing number of diagnosed HIV infections observed in Saskatoon has been associated 
with the high rate of risky behaviors such as IDUs and unsafe sexual practices (Bird et al., 2016). 
With the increase in the number of IDUs among indigenous people in Saskatoon, the number of 
unsafe needles sharing among the population also contributed to the burden of HIV in the city 
(Saskatchewan Ministry of Health, 2014). In addition, majority of the indigenous people in 
Saskatoon live in areas with higher rates of unemployment, lower education, low income cut-
off and higher rates of inadequate housing, all of which could increase their vulnerability to HIV 
infection (Saskatchewan Ministry of Health, 2014).  
MENTAL HEALTH/DISORDER  
The World Health Organization (WHO) defines mental health as “a state of well-being in which 
an individual realizes his or her abilities, can cope with the normal stresses of life, can work 
productively and is able to make a contribution to his or her community” (World Health 
Organization, 2014). Mental illnesses encompass a range of disorders that can negatively affect 
our mood, thoughts and actions (Center for Disease Control and Prevention, 2018b). Currently, 






(World Health Organization, 2017). According to the model of Risk Analytica in Toronto, Canada, 
it was observed that over 6.7 million people (9 years and older) suffered from mental illness in 
2011, and one in five Canadians is likely to develop a mental disorder (Smetanin et al., 2011). 
MENTAL HEALTH OF PLWHA 
Often, being diagnosed with HIV infection results in an initial shock of positive serology test, 
panic over disease advancement, fear of being neglected by family and friends and worries about 
disease transmission (Gerbi et al., 2012). Besides advancing opportunistic infections that PLWHA 
often face, these emotional burdens could also result in potential mental disorders such as 
depression in HIV infected individuals ( Gerbi et al., 2012). Depressive disorders are more 
common in PLWHA when compared to the general population (Baingana et al., 2005 ; Nosrat et 
al., 2017).  
OVERVIEW OF DEPRESSIVE DISORDERS  
 “Depression is a multifactorial disorder with clinically heterogeneous features involving 
disturbances of mood and cognitive function” (Gong and He, 2015). According to Diagnostic and 
Statistical Manual of Mental Disorders V (DSM-V), depressive disorders are classified based on 
the severity, time and causes of the depressive disorder(s) into major depressive disorder (MDD), 
persistent depressive disorder (PDD), premenstrual dysphoric disorder, disruptive mood 
dysregulation disorder, substance induced mood disorders and mood disorders due to medical 
conditions (American Psychiatric Association, 2013).  
Major depressive disorder (MDD) is a mental illness with symptoms including loss of interest in 
daily activities, insomnia or excessive sleep, weight loss or gain not attributable to dieting or 






lasting for a minimum period of two weeks subsequently impacting sufferers ability to function  
(Belmaker and Agam, 2008).  
Persistent depressive disorder (PDD), previously known as dysthymia lasts for a minimum period 
of two years in adults and one in children (American Psychiatric Association, 2013). The onset of 
PDD is gradual and it produces more harmful effects such as functional impairment and suicidal 
thought and ideation over time (Melrose, 2017). 
Premenstrual dysphoric disorder (PMDD) occurs before monthly menstruation in menstruating 
women and disappears shortly after menstruation (American Psychiatric Association, 2013). 
“Mood and behavioural symptoms such as irritability, tension, depressed mood, and mood swing 
are the most distressing, however, breast tenderness and bloating can also be an issue with PMDD.” 
(Yonkers et al., 2008). 
Disruptive mood dysregulation disorder (DMDD) consists of irritable behavior or excessive 
temper outbursts (in the form of verbal or behavioral) in children below 10 years. Children with 
DMDD consistently display noticeable irrational behaviors thrice or more a week for over a year 
(American Psychiatric Association, 2013; Dougherty et al., 2014).  
PROGNOSIS OF DEPRESSIVE DISORDERS 
Generally, the onset of depressive disorders occurs in the mid-twenties but may begin in 
adolescence through adulthood. Some cases of depressive disorders may appear in infants and 
young children (Mueller and Leon, 1996; Fava and Kendler, 2000). The onset of depressive 
disorders (prodrome) varies considerably among individuals. Some people may present with 
symptoms such as anxiety, panic attack etc. that are due to stressful life events, while others may 






GLOBAL BURDEN OF DEPRESSIVE DISORDERS 
The global estimate of depressive disorders is still unclear because depressive disorders remain 
largely under-diagnosed among the general population (Patten, 2015). Although depressive 
disorders are a worldwide health challenge, the prevalence of depressive disorders is difficult to 
estimate due to poor mental assessment strategies across nations (Murray and Lopez, 1996; 
Rosmond, 2004).  However, recent evidence according to World Health Organization showed that 
over 322 million individuals suffered from depression in 2015 (World Health Organization, 
2017a).  
The WHO postulated that depressive disorders would account for the world’s second most 
common cause of global disease burden by 2020 and the most common cause of disability by 2030 
(World Health Organization, 2001). Knoll and MacLennan examined the prevalence of depression 
in Canada using the data from Canadian Community Health Survey- Mental Health (CCHS-MH) 
focus content cycle 2012, and observed a lifetime prevalence rate of 11.2%. They also found that 
women are 1.8 times more likely than men to suffer from major depression in their lifetime (Knoll 
and MacLennan, 2017). 
SIGNS / SYMPTOMS OF DEPRESSIVE DISORDERS 
Depressive disorders generally present with loss of interest in life/daily activities, low self-esteem, 
insomnia, fatigue, loss of concentration, psychomotor retardation, sluggish movement, suicidal 
thoughts and health-related functional and cognitive impairments (Olatunji et al., 2006; Ownby et 
al., 2010; Ndu et al., 2011; National Institute of Mental Health, 2016). The severity of depressive 
symptoms depends on the stage of the disorders and the nature of the accompanying illnesses 






CAUSES OF DEPRESSIVE DISORDERS 
The etiology of depressive disorders is multifactorial, with biological, social and psychological 
variables all found to be contributory (Ramasubbu et al., 2012; Chibanda et al., 2014; Nanni et al., 
2015). Biological causes are thought to be due to differences in genetic makeup and/or chemical 
imbalances in the body. A possible explanation of a biological cause of depressive disorder is the 
imbalance in monoamine neurotransmitters such as serotonin and noradrenaline (Fu et al., 2001; 
Healy, 2001; France et al., 2007). Serotonin is the neurotransmitter that is responsible for 
regulating mood, sleep, aggression, sexual behavior et cetera in the body, and a decrease in the 
level   of serotonin could result in depressive disorders (Nemade et al., 2017).  
Another popular theory is the catecholamine hypothesis, which suggests that a decline in nor-
epinephrine (excitatory hormone) can lead to depressive mood (Lambert et al., 2000; Nemade et 
al., 2017). A major deficiency of the catecholamine hypothesis is that there are no known gold 
standards to measure the amount of neurotransmitter in the brain (Nemade et al., 2017). Social 
contributors include pre-disposing adverse life events such as job loss, geographical isolation, 
bereavement, broken relationships/marriages, redundancy, sustained physical injury, childhood 
traumatic experiences, health-related illnesses and poor social support network (Rashmi, 2017). 
Psychological contributors include psychodynamics, cognitive and behavioral factors. Unhealthy 
self-perceptions can also lead to depressive disorders over time (Wright et al., 2012).  
EFFECTS OF DEPRESSIVE DISORDERS 
Depressive disorders when not given prompt medical attention may become chronic,  severe or 
recurrent and could impair an individual's daily responsibilities and obligations (World Federation 
for Mental Health, 2018). More severely, depressive disorders can result in suicidal ideation 






viewpoint, the cost of treating mental related illnesses is 4.2 times higher than the cost of treating 
a population without mental illness (World Health Organization, 2014). 
TREATMENT OF DEPRESSIVE DISORDERS 
Depression is a treatable illness (Pratt and Brody, 2008). The treatment options for depressive 
disorders or symptoms depend on the stage of the illness. The treatment of depressive disorders 
can be categorized into acute, continuation and prophylactic treatment options. Treatment 
therapies are targeted towards the treatment of ongoing depressive disorders. Examples include 
psychotherapies and antidepressant drugs (Anderson et al., 2010; Gautam et al., 2017).  
Optimum adherence to antidepressant drugs and psychotherapies has been proven to be effective 
in the treatment of debilitating effects of depressive disorders (Gautam et al., 2017). A popular 
adopted model for treatment of depression is the stepped care model. The stepped care model aims 
to improve mental healthcare access between the patients and the service providers ( National 
Collaborating Centre for Mental Health, 2004). The model suggests a framework progressing from 







Figure 2.4: Stepped Care Model 
 
Source: Investigating the use of NICE guidelines and IAPT services in the treatment of depression 
(Gyani et al., 2012: p151). 
 
DEPRESSIVE DISORDERS AND HIV 
Depressive disorders and HIV infection are highly comorbid (Bing et al., 2001; Choi et al., 2016). 
For example, the comorbidity of depressive disorders with HIV infection was evident in a meta-
analysis of ten studies carried out by Ciesla and Robert in 2001. It was observed that being 
diagnosed with HIV infection was associated with elevated odds of depressive disorders (Ciesla 
and Roberts, 2001).  
Global reports on the actual prevalence of mental disorders in PLWHA are diverse due to wide 
variation in the data used to generate the estimates. However, the prevalence of depression among 
PLWHA varied from 22% (Campos et al., 2010) to 71% (Savetsky et al., 2001). The burden of 






the prevalence of self-reported depression in United States was observed to be thrice as common 
in PLWHA compared to the general population (Do et al., 2014). The co-existence of depressive 
disorders with HIV infection could be as high as 63% in Cameroun (L’akoa et al., 2013). Also, a 
survey from the University of Nigeria teaching hospital, Nsukka observed that one in five 
individuals with HIV/AIDS met the criteria for depressive disorders based on the hospital anxiety 
and depression scale (Ndu et al., 2011). 
The effects of comorbid depressive disorders with HIV infection are far-reaching. The comorbidity 
of depressive disorders/symptoms with HIV infection may influence the decline in CD4+ cell 
counts, elevate blood viral level (Rivera-Rivera et al., 2016) and reduce treatment adherence in 
PLWHA (Gonzalez et al., 1999).  
FACTORS ASSOCIATED WITH DEPRESSIVE DISORDERS IN PLWHA 
Social-demographic Variables: Age 
Depressive disorders are more common in children and young adults (Cesar and Chavoushi, 2013). 
The social, medical, psychological, and neurological effect of HIV infection on the developing 
brain could account for the high prevalence of mental health disorders among adolescents 
(Kemigisha et al., 2019). However, depression at older ages comes with more severe health risks 
(Girling et al., 1995; Fiske et al., 2009).  
The number of older PLWHA with depressive disorders is increasing. Treatment adherence has 
increased the life expectancy of older PLWHA who might have been diagnosed with depressive 
disorders/symptoms earlier in life (Mills et al., 2011; Cahill and Valadez, 2013; Liu et al., 2014). 
Liu et al. (2014) in Nanning, China examined the psychological impacts  
of HIV infection on older (50 years and above) and younger (18 to 49 years) PLWHA, the authors 






younger patients (Liu et al., 2014). Similarly, a study in Uganda observed that PLWHA above the 
age of 50 are 1.93 times more likely to self-report depressive symptoms when compared to 
participants between the ages of 18 to 30 (Kaharuza et al., 2006).  
Positive serology comes with severe health challenges especially with advancement in age. Older 
individuals with HIV/AIDS often experience a significant decline in their immune function and 
impairment in their physical abilities which may limit their ability to access treatment (Nichols et 
al., 2002; Liu et al., 2014). Participants from the study of Liu and colleagues highlighted that the 
stress of keeping up with routine medical care, financial constraints, and minimal social support 
are responsible for increased depressive symptoms (Liu et al., 2014).  
Contrarily, Anagnostopoulos et al. (2015)  in Switzerland examined the frequency and the risk 
factors associated with clinically diagnosed depressive disorders in a Swiss HIV cohort and 
observed that aging had a protective effect on depressive disorders among MSM, heterosexual 
men and men who inject recreational drugs (Anagnostopoulos et al., 2015). Also, a cross-sectional 
survey of Rai and Verma. (2015) found no significant association between age and self-reported 
depression among PLWHA in Uttar Pradesh, India. 
Gender 
With few exceptions, the onset, severity and prevalence of depressive disorders are higher in 
females than in males. The depressive disorders in females typically begin in mid-puberty and 
continue through adulthood (Piccinelli and Wilkinson, 2000). While trying to explore the likely 
causes of elevated odds of depression in females, Schreiber in her book “women’s experiences 
with depression” says depression is a social disease that affects females due to gender-specific 
stressful life experiences. Schreiber listed  infertility, miscarriages, perinatal period, adverse 






responsible for elevated odds of depressive symptoms in female participants in Vancouver 
(Schreiber, 2001). In her study, the participants through interviews further highlighted oppression, 
marginalization and domestic violence as the cause(s) of their depression disorders/symptoms 
(Schreiber, 2001).  
Also, how males and females react to somatic symptoms (tiredness, unusual rhythm in sleep and 
eating pattern) could increase their vulnerability to depressive disorders (Silverstein, 1999). 
Studies have reported that females are more likely than males to complain of anxiety and somatic 
symptoms (Silverstein, 1999; Silverstein et al., 1995). After adjusting for all forms of anxiety and 
other somatic symptoms, Silverstein et al., (1999) observed no gender differences in the rate of 
depression among their participants (Silverstein, 1999).  
In PLWHA, Aljassem et al. (2016) observed elevated odds of depressive symptoms among 
females than in males Ontario residents (Aljassem et al., 2016). Also, the multivariate analysis by 
Bhatia et al. (2011) in Houston, Texas found a stronger association between depressive symptoms 
among females than in males who were newly diagnosed with HIV infection (Bhatia et al., 2011). 
Furthermore, Morrison et al. (2002) in Florida determined  
that seropositive women are four times more likely to  report depressive disorders than 
seronegative women (Morrison et al., 2002).  
In contrast, Mohammed et al. (2015) in Ethiopia found that males PLWHA are 1.6 times more 
likely to be depressed than females PLWHA (Mohammed et al., 2015). However, the authors 
pointed out that the study was carried out among participants from a specific population, and that 
the methodology was prone to recall bias, all of which may affect the generalizability of their 






gender and self-reported depression among PLWHA in Uttah Pradesh, India (Rai and Verma, 
2015).  
Various studies have observed a stronger association between chronicity of depressive disorders, 
and rapidity of HIV progression in males than in females (Leserman, 2008) but higher mortality 
in females than in males (Ickovics et al., 2001; Antelman et al., 2007; Aljassem et al., 2016). A 
nine-year follow up study on HIV homosexual men in San Francisco observed that HIV infection 
advances to AIDS 1.5 years sooner in males with depressive disorders compared to males without 
depressive disorders (Leserman, 2008). 
Ethnicity 
The rates of major depression differ globally and across various cultures (Kessler and Bromet, 
2013). Cross-cultural beliefs according to ethnomedical sciences have observed differences in 
people’s perception and acceptance of depressive disorders among various ethnic groups (Rashmi 
et al., 2007). Ethnicity can also influence the biological makeup of people making them more 
vulnerable to depression (Rashmi et al., 2007). Kirmayer et al. (2000) examined the mental health 
of Aboriginal people in Canada and observed that indigenous communities have experienced 
cultural changes and being marginalized in societies and at workplace. They emphasized that the 
disengagement in the culture of indigenous people has resulted in high rate of depressive 
symptoms, drug uses, excessive alcohol consumption and suicidal ideation amongst them 
(Kirmayer et al., 2000).  
Studies across nations on different population groups found out that ethnicity is positively 
associated with depressive disorders/symptoms in individuals infected with HIV/AIDS (Nelson, 
2002; Williams and Mohammed, 2009; Loutfy et al., 2012; Pellowski et al., 2013; Cano et al., 






other social factors to limit the diagnosis and expression of depressive disorders/symptoms 
(Nelson, 2002; Williams and Mohammed, 2009; Pellowski et al., 2013). Cain et al. (2013) 
interviewed some indigenous people across Canada and authenticated colonization, stigmatization 
and risky behaviors as the underpinning factors for higher rates of depressive disorders amongst 
them (Cain et al., 2013).  
In 2013, Wong et al. (2013) examined the causes of mental health disorders among non-status 
immigrants with HIV infection in Toronto, and they discovered that racism, discrimination, 
sexism, social isolation and immigration problems were significantly associated with depressive 
disorders (Wong et al., 2013). Similarly, Chen et al. (2014) observed increased depressive 
symptoms among non-status immigrants (Asian and Pacific Islanders) living with HIV infection 
in San Francisco and New York City. In the same study, the majority of the respondents attested 
that the difficulties experienced in adapting to an entirely new environment negatively affected 
their mental health (Chen et al., 2014).  
Employment 
Employment is important in maintaining income and standard of living most especially in people 
with long-lasting illnesses (Greenwald et al., 1989). Studies conducted in Western countries 
consistently reported high unemployment rates among PLWHA, ranging from 45 to 65% (Ezzy et 
al., 1998; Kupek et al., 1999; Vitry-Henry et al., 1999; Dray-Spira et al., 2003). The association 
between employment status and depressive disorders in PLWHA has been well-researched, and 
the association was linked to the incapacitating effect of HIV infection on affected individuals 







For instance, a study examined the association between changes in employment status and its effect 
on depression among 7,368 Korean adults observed that changing from a permanent employment 
to casual jobs elevated the risk of reporting depressive symptoms by 1.45 (95% CI: 1.23-1.70), 
and by 1.78 (95% CI: 1.30-2.43) among participants that changed from full time employment to 
being unemployed (Yoo et al., 2016). In addition, Bhatia et al. (2011) in Houston, Texas 
determined that being unemployed elevated the risk of self-reported depressive symptoms by 1.54 
in PLWHA (Bhatia et al., 2011). Conversely, Karina et al. (2017) in São Paulo, Brazil found the 
risk of depressive symptoms to double among participants currently employed and above the age 
of 40 compared to unemployed PLWHA (Karina et al., 2017). 
The effects of unemployment on PLWHA have been documented in several studies. 
Anagnostopoulos et al. (2015) observed that being unemployed was a risk factor for reporting 
depressive disorders among Swiss PLWHA (Anagnostopoulos et al., 2015). Maruthappu et al. 
(2017) found unemployment to increase HIV mortality among Organization of Economic Co-
operation and Development (OECD) member states (Maruthappu et al., 2017), while Voss et al. 
(2004) observed elevated suicidal related mortality among Swedish PLWHA with depressive 
disorders (Voss et al., 2004). Therefore, it is expedient to see employment beyond making a living 
and view its long-term effect on self-image, social integration and psychological wellness 
(Nordenmark, 1999). 
Marital Status  
Some studies have suggested that married individuals have fewer psychological illnesses and may 
be physiological healthier than never married, separated, divorced or widowed (Ross et al., 1990; 






integration (House et al., 1988). However, it has also been well-recognized that marital problems 
can be a threat to personal health and wellbeing in marriage (Robles et al.,  2014).  
Conflicting findings exist in the literature regarding the association between depressive disorders 
and marital status of various individuals. For instance, Rong et al. (2017) in Wuhan, Hubei, China 
observed that being married or living with a partner increased the odds of reporting depressive 
symptoms by 2.40 among PLWHA(Rong et al., 2017). Meanwhile, Egbe et al. (2017) determined 
that single PLWHA were 2.81 more likely to report depressive disorders compared to married 
PLWHA in Nigeria (Egbe et al., 2017). Although factors responsible for varying rates of 
depressive symptoms among married and never married individuals living with HIV infection 
from above studies were not reported, differences may be due to the methodological approaches 
and the method of recruitment of their study participants. 
Social Support 
 Social support refers to supportive functions performed for individual(s) by significant others, 
such as family members, friends, and coworkers (Thoits, 1995). Social support can be emotional, 
informational or instrumental (Bekele et al., 2013). Social support forms a significant component 
of the biopsychosocial etiological model of depressive disorders (Wright et al., 2012). Various 
studies have shown that providing consistent social support to individuals living with HIV/AIDS 
infection can help to reduce the burden of depressive disorders/symptoms amongst them 
(Vyavaharkar et al., 2010; Liu et al., 2013; Liu et al., 2014; Kingori et al.,  2015; Matsumoto et 
al., 2017; Thai et al., 2017).  
Bekele et al. (2013) in Ontario, Canada examined both the direct and indirect effects of perceived 
social support on the physical and mental wellbeing of a cohort of about 602 Ontario residents 






physical and mental wellbeing on the participants (Bekele et al., 2013). The authors also found 
that PLWHA with perceived social support were less likely to report depressive symptoms when 
compared to those participants without social support (Bekele et al., 2013). Consistent social 
supports in individuals living with HIV/AIDS could significantly reduce depressive disorders 
(McDowell and Serovich, 2007; Mavandadi et al., 2009), increase patient’s adherence to ART 
therapy (Vyavaharkar et al., 2007) and boost their CD4+ cell counts (Persson et al., 2002). 
Discrimination and Stigmatization 
People with certain health conditions are often being discriminated and prejudiced (Valdiserri, 
2002; Link and Phelan, 2006; Wailoo, 2006). A study In the United State observed that HIV 
infection was perceived as an illness that results from the person’s responsibility and action 
because the modes of transmission are mostly behavioral that are voluntary and avoidable (Herek 
and Capitanio, 1998), leading to negative perception of PLWHA as people lacking moral values 
(Foreman, 1999; Varga, 1999). Chandra et al. (2005) in India examined the factors associated with 
depressive disorders among PLWHA and most participants accentuated stigmatization over all 
other potential factors underpinning their depressive disorders (Chandra et al., 2005).  
Similarly, a report from the Joint United Nations Programme on HIV/AIDS gathered national data 
from countries with available literature observed that 50% of people had discriminatory behaviors 
towards individuals with HIV/AIDS. Approximately one in eight PLWHA was denied healthcare 
access due to rejection and stigmatization in healthcare facilities (Joint United Nations Programme 
on HIV/AIDS, 2015). The outcomes of stigma and discrimination are widespread in PLWHA 
(Katz et al., 2013; Stangl et al., 2013). Stigma and stigmatization have eroded many PLWHA of 
their rights, means of livelihood, marriages and access to HIV treatment (Katz et al., 2013; Stangl 






BEHAVIORAL RISK FACTORS 
Substance Use: Alcohol Use 
The prevalence of alcohol use disorder is higher in PLWHA than in general population (Cook et 
al., 2001;Petry, 1999; Samet et al., 2004). According to American Addiction Centers. (2018), 
people indulge in excessive alcohol consumption when faced with unfavorable life conditions as 
a means of coping with depressive symptoms. Unfortunately, the effect of alcohol consumption as 
a coping strategy is ephemeral (American Addiction Centers, 2018). Excessive alcohol 
consumption often lead to alcohol dependence that may impact daily activities and work 
obligations (American Addiction Centers, 2018). Moreover, frequent alcohol intake can reduce 
the level of serotonin neurotransmitter in the brain.  
Serotonin is known as a mood stabilizer and excessive alcohol consumption can reduce the level 
of this neurotransmitter in the brain leading to a depressed or lowered mood (American Addiction 
Centers, 2018). Sullivan et al. (2008) examined the impact of alcohol use on depressive symptoms 
in HIV infected patients with current or past alcohol problems using data from HIV-Longitudinal 
Interrelationship of Viruses and Ethanol (HIV-LIVE) and observed that current alcohol 
dependence was significantly associated with increased depression score on Center of 
Epidemiology Studies Depression (CES-D) scale (Sullivan et al., 2008). 
Cocaine Use 
Depressive disorders are frequently observed among frequent cocaine user with HIV infection. 
Hammond et al., (2016) in Baltimore, Maryland observed the prevalence of cocaine use to be 
81.4% among African American PLWHA who were depressed to 69.3% who were not depressed. 
Also, the authors observed a two-fold  increased odds of depression among cocaine users compared 






Injection and Other Non-Injection Drug Users  
Injection drug users are more likely to get infected with HIV, and to report major depression 
(Brook et al., 2002). Physical, psychological and social dysfunctions resulting from injection drug 
addictions may negatively affect the mental health of injection drug users over time (Li et al., 
2014). Several studies have observed the risk of depressive symptoms to be higher in people who 
use injection or non-injection drugs (Bing et al., 2001; Anagnostopoulos et al., 2015). Carrico et 
al. (2007) in United States observed that PLWHA using stimulants had 5 times higher viral loads 
than non-stimulant users (Carrico et al., 2007).  
Incarceration 
HIV infected individuals are overrepresented in prisons. Substance abuse and mental related 
illnesses are also frequently reported among inmates in various nations (Bing et al., 2001; 
Hammett et al., 2002). Lack of freedom and the need to comply to an entirely distinct rules and 
regulations may pose a significant threat to the mental health of inmates. Also, where applicable, 
the pre-existing adverse life events before being incarcerated may result to depressive cognition 
among inmates in the United States (Boterrell, 1984). Shrestha et al. (2017) in Eastern Nepal 
observed that the rates of reporting depressive symptoms is 1.97 times more common among 
inmates with prior history of incarceration compared to those inmates without prior incarceration 
history (Shrestha et al., 2017).   
Men who have Sex with Men (MSM)/Homosexual men 
Studies have shown that homosexual males are at higher risk of depressive symptoms than 
heterosexual men (Ahaneku et al., 2016; Choi et al., 2016). For instance, a study in Netherlands 
observed that MSM are 3 times more likely to report depressive symptoms than heterosexual men 






symptoms: 22.8% to 33% in MSM than it is for heterosexual men (Perdue et al., 2003; Reisner et 
al., 2009; Fendrich et al., 2013; Hammond et al., 2016). In developing countries, few studies have 
examined the association between HIV infection and depressive disorders/symptoms in 
homosexual men. In Tanzania, the rate of depressive disorders/symptoms is 46.3% among HIV 
infected homosexual men (Ahaneku et al., 2016). Sociocultural and civil stigma that confront 
homosexual men in Tanzania is responsible for the higher rate of depressive disorders/symptoms 
observed among the group (Ahaneku et al., 2016).   
CLINICAL RISK FACTORS 
Studies that examined the association between clinical parameters and the risk of depressive 
disorders/symptoms on PLWHA are limited. However, this section will explore the association 
between CD4+ cell counts, viral load and the risk of depressive disorders/ symptoms among 
individuals with HIV from reported studies.    
CD4 Cell Counts 
From a clinical perspective, studies have suggested that the chronicity of depressive disorders 
correlates with rapid decline in CD4+ cell counts (Hughes et al., 2004; Boarts et al., 2006), and an 
increased viral load (Ndu et al., 2011). This implies that failure to treat depressive disorders may 
accelerate HIV disease progression and reduce life expectancy of PLWHA over time (Ickovics et 
al., 2001; Ndu et al., 2011). Ickovics et al. (2001) in Baltimore, USA  observed that a depressive 
disorder lasting for more than seven years was associated with significant reduction in CD4+ cell 
counts in female PLWHA (Ickovics et al., 2001)   
Viral Load 
Several authors have attested that the severity of depressive disorders correlates with elevated viral 






(2007) in USA observed a 50% increase in mean viral loads of patients as their depressive 
disorders/symptoms become more several (Carrico et al., 2007). This study also tested other 
clinical variables for their association with self- reported depressive symptoms in PLWHA. These 
variables include liver enzymes aspartate aminotransferase (AST), gamma-glutamyl-transferase 












The framework for our study was adopted and modified from the study of Kinyanda et al.’s (2011) 
in Uganda that examined the prevalence and the risk factors for major depressive disorders among 
individuals living with HIV/AIDS in semi-urban Entebbe district of Uganda (Kinyanda et al.,  
2011). Kinyanda et al.’s (2011) conceptual framework was based on the Diathesis-Stress Model – 
this model gives the detailed description on how the genetic components and biological factors act 






collaboratively with environmental stress to result in an illness (Goforth et al.,  2011; Kinyanda et 
al., 2011).  
More precisely, the model suggested that stressful life events could trigger individual's 
vulnerabilities to some specific psychological disorders. Diathesis-Stress Model expatiated that if 
the at-risk individuals have low resilience or vulnerability for a particular disorder, an extremely 
high level of stress would be needed to initiate the symptoms of such disorder and vice versa 
(Goforth et al., 2011). Our study framework identified biopsychosocial factors predisposing 
individuals to major depression. Also, the neurotoxic effects of HIV infection reinforced by the 
stress of managing HIV infection can increase individual’s vulnerability to major depression. See 






Figure 2.6:  Study Framework 
 
Adapted and modified from “Prevalence and risk factors of major depressive disorder in 
















CHAPTER 3: METHODOLOGY 
 
This chapter focuses on the theoretical perspectives, research design and rationale used in this 
study. The latter part gives the detailed descriptions of the study variables, population, location 
and the statistical procedures employed in the study.  
STUDY DESIGN  
Our study is a cross-sectional study from medical charts of PLWHA that accessed care at Positive 
Living Program (PLP) at the Royal University Hospital (RUH) in Saskatoon, Saskatchewan, 
Canada. 
STUDY LOCATION 
The study data collection was conducted at the PLP of the RUH. PLP was established to provide 
care and support for seropositive patients residing in Central and Northern Saskatchewan. The 
mission is to provide comprehensive, multi-disciplinary, patient-centered health care and social 
support to individuals living with HIV/AIDS and Hepatitis C Virus (HCV) patients at no cost 
through their program offices at RUH and Westside community clinic (Saskatchewan Health 
Authority, 2017). Other services that patients received during their visit to the unit include 
counselling, immunization, clinical assessment and treatment evaluation strategy (Saskatchewan 
Health Authority, 2017). 
STUDY POPULATION 
This study included seropositive adult persons age 18 and older receiving care and monitoring at 






OPERATIONAL AND ETHICAL APPROVALS 
Ethical approval was obtained from the University of Saskatchewan Behavioral Research and 
Ethics Board (Bio 14-290). This was to ensure compliance with university regulations and to 
establish proper research administration oversight. During data extraction, we ensured that only 
needed variables were extracted from the medical charts while maintaining confidentiality. All 
data was coded with password encryption. All stored data will be discarded through electronic file 
deletion after five years. 
DATA COLLECTION 
The PLP data was collected from September 1 to November 31, 2016. Data was collected 
prospectively from patients’ medical charts from 2010 to 2015. The data was directly entered in a 
password encrypted excel sheet. The variables that were gathered include socio-demographic 
variables (sex, ethnicity, age, housing status, transportation status, marital status, employment 
status, and available support network), behavioral risk factors (MSM, substance use and history of 
incarceration) and clinical parameters (CD4 cell counts, viral load test and liver enzymes). 
Two available standardized medical forms were available for data collection. These were the 
Saskatoon Health Region HIV Case Reporting Form and HIV Initial Assessment Form. Both 
forms contain patient’s socio-demographic and behavioral factors, which were all check-marked 
by the attending nurse during a brief interview with each patient at their first visit to the site. Please 
refer to Appendix G for the copy of this form. Clinical variables were obtained from laboratory 








DESCRIPTION OF VARIABLES 
Outcome Variable (Baseline)  
Depressive Symptoms – The attending nurse during the patient’s first visit to PLP assessed the 
self-reported response. Patients were asked if they were depressed or not. The dichotomous 
variable (self-reported depressive symptoms) was coded as “yes or no.” 
Independent Variables (Baseline) 
Socio-demographic factors 
Age – This was obtained from HIV case reporting form. We categorized age into 10-year intervals.  
Gender – Information on gender was obtained from HIV case report form. Gender was classified 
as male, female and other (transgender). 
Ethnicity – This was obtained from HIV initial assessment form. The categories include White, 
Black (e.g. African, Haitian, Jamaican, Somali, etc.), First Nations, Métis, Inuit, Asian (e.g. 
Chinese, Japanese, Vietnamese, Cambodian, Indonesian, Filipino etc.), South Asian (e.g. East 
Indian, Pakistani, Sri Lankan, Punjabi, Bangladeshi, etc.), Arab/West Asian (e.g., Armenian, 
Egyptian, Iranian, Moroccan, etc.), Latin-American (e.g. Mexican, Central/South American, etc.), 
or other ethnicities. In our analysis, ethnicity was categorized distinctly into three groups namely: 
Caucasian (patients self-identified as white of Canadian descent), Indigenous (self-identified 
descend as either North American Indian, Métis and Inuit), and Others (patients from Africa, 
Asian, South Asian, West Asian, Latin America etc). 
Marital Status – This was assessed from the medical chart, which included single/never married, 
married and separated/divorced/widowed. This study categorized marital status into single/never 






Employment Status – This was obtained from the HIV initial assessment form. Patients were 
asked if they were employed or unemployed at their first visit to the site.  
Available Transportation and Housing – The information on housing and transportation were 
obtained from HIV initial assessment form. Patients were asked to disclose any issues relating to 
housing or transportation that might affect their subsequent visits to PLP. 
Social Support – This is also available in HIV initial assessment form. The available social 
support for patients was categorized as formal (government support) or informal (family, friends 
or both). 
Behavioral Factors (Baseline) 
Men who have sex with men (MSM) – This HIV risk was self-reported and recorded by the 
attending healthcare practitioner. MSM was categorized into yes and no.  
Injection Drug Use (IDU) – This was obtained from the patient initial assessment form. It was 
self-identified by patients. This is categorized into yes/no options. 
History of Incarceration – This was available from the patient initial assessment form. Prior 
history of incarceration was self-reported by each patient at their initial visit to PLP. This response 
was classified as yes/no.  
Smoking – This was obtained in the HIV case report form. This was self-identified and recorded 
by the attending nurse. Smoking status was categorized as yes or no. 
Alcohol Consumption – This was assessed from the patient initial assessment form. It was self-
identified and checkmarked by attending nurse. Alcohol intake was categorized as yes or no. 
Cocaine Use – This was also obtained from the patient initial assessment form. Cocaine use was 






Marijuana Use – This HIV risk was self-reported and checkmarked by the attending nurse and 
classified accordingly into yes/no.  
Clinical Parameters (First available clinical/laboratory test)  
Viral Loads – This was obtained from the first available clinical/laboratory test report from the 
patient medical chart. The viral load of each patient was tested periodically to check the 
effectiveness of the ART treatment options.  
CD4 Cell Counts – The periodical laboratory test report in the patient medical chart was being 
assessed to obtain the CD4 cell counts of each patient. In our analysis, we categorized CD4 cell 
counts into three according to Center for Disease Control (CDC) classification into low  (< 200 
cells/μl), medium (200-500 cells/μl) and normal (> 500 cells/μl) (Vajpayee et al., 2005). 
AST – This was obtained from laboratory test report in the patient medical chart. For ease of 
analysis, we grouped AST into normal (<45 U/L), mild (46-135 U/L) and high (>136 U/L) (Liver 
Doctor, 2018). 
ALT – This was obtained from laboratory test report in the patient medical chart. For ease of 
analysis, we grouped AST into normal (< 45 U/L), mild (46-135 U/L) and high (>136 U/L) (Liver 
Doctor, 2018). 
INCLUSION CRITERIA 
All HIV positive individuals accessing care at the PLP in Saskatoon from 2010 to 2015 were 










The outcome variable of interest in this study was self-reported depression. Baseline self-reported 
depression was coded and extracted as “yes/no” from the patient medical chart.  
Independent Variables 
Variables that were known to be associated with self-reported depression in individuals living with 
HIV/AIDS as identified earlier in the literature were categorized into socio-demographic, 
behavioral, and clinical variables. Some of the independent variables had large amount of missing 
data and were problematic in the analysis. The independent variables of interest considered for 
analysis are summarized in Table 3.1. 
Table 3.1: Baseline Independent Variables 
Categories Variables Description Type 
Demographic 
(Baseline) 




                           
Marital Status 
                     




Transportation           
                       
Available Housing 
Male, Female and Others 
Birth Date 
Caucasian, Indigenous, Black 
and Others 
Single/Never Married, Married 
and 
Separated/Divorced/Widowed 
Yes or No. 
 
Yes or No. 
Yes or No. 
 
Yes or No. 
 























A purposeful variable selection approach for logistic proposed by Hosmer and Lemeshow was 
followed by exploring the univariate analysis of all independent variables at P < 0.05 (Bursac et 













































































al.,  2008). Table 4–3 shows the univariate analysis for all independent variables considered for 
potential inclusion in the final model. To align with the principle of parsimony and to avoid 
inflation of standard errors, multicollinearity analysis using test of tolerance and variance inflation 
factors of the independent variables was conducted as a parameter reduction strategy. See 
Appendix 1 to 3 for multicollinearity analyses. After multiple iterations of fitting the multivariable 
model to assess the relationship between the independent variables and our outcome of interest, a 
backward model-building approach was applied to arrive at the final predictive model. 
Multivariable analysis was conducted at P < 0.05. Confounding and biologically plausible 
interactions of other non-significant independent variables were explored. However, none of the 
non-significant independent variable was found to be confounding or modifying the existing 
association in the multivariable model. 
STATISTICAL ANALYSIS 
Descriptive statistics were used to summarize the data by reporting on the mean and standard 
deviation. To assess baseline characteristics, t-test was used for continuous variables and 
dichotomous variables were assessed using chi-square or Fishers exact test. For the univariate 
analysis, several logistic regression models were used to assess the association between the 
independent variables and self-reported depressive symptoms. Due to the high level of missing 
data, a backward stepwise selection approach was used for our multivariate analysis. 
Corresponding p-values and 95% confidence intervals for the regression coefficients were also 









CHAPTER 4: RESULTS 
STUDY POPULATION BASELINE CHARACTERISTICS                                    
Sociodemographic Variables 
A total of 351 PLWHA were included in this study. Of them, 220 (62.9%) males, 129 (36.8%) 
females and 1 (0.3%) self-identified as a transgender. 113 (32.3%) self-reported depressive 
symptoms at baseline, 18 (5.1%) denied depressive symptoms and 219 (62.6%) were missing data 
for depressive symptoms. The study mean age was 45.2 years (SD = 11.8) and most of the patients 
280, (79.7%) were between 30 - 59 age range. 169 (48.3%) patients were from indigenous ancestry, 
100 (28.6%) Caucasian, 17 (4.8%) Black, 17 (4.8%) other ethnic groups and 48 (13.7%) were 
missing ethnicity data. Of the total 351 patients, 146 (41.6%) identified their marital status, 81 
(23.1%) single, 45(12.8%) married and 20 (5.7%) were separated, divorced or widowed.  
Behavioral Variables  
181 (51.6%) patients reported their sexual identities, 63 (18%) self-identified as MSM/homosexual 
men and 106 (30.3%) denied MSM practices. 153 (43.7%) patients reported recent history of IDU 
and 110 (31.4%) denied IDU. 60 (17.1%) patients reported prior incarceration history and 39 
(11.1%) denied prior incarceration history. The smoking status of 235 (67%) patients was 
gathered, 190 (54.3%) reported cigarette smoking and 45 (12.9%) self-identified as non-smoker. 
148 (42.3%) patients reported alcohol consumption and 61 (17.4%) denied alcohol intake. 
Clinical Variables 
From the 351 patients in our study, 305 (87.1%) patients had their CD4 cell counts measured at 
initial diagnosis. From the available data, 73 (20.9%) had a low CD4 cell counts (<200 cells/μl), 






(>500 cells/μl). The mean CD4 cell counts was 374 cells/μl.  See Table 4–1 and 4–2 for the study’s 
baseline characteristics. 
Table 4.1: Baseline Patient’s Characteristics (N=351) 



























Indigenous (First Nation, 


















































Variables N % 





























































Any Social Support 



















Variables N % 

















































































































































































Table 4.2: Independent Baseline Variables and Self-Reported Depressive Symptoms Status (n, 
%) 

























































































































































































Covariates Depressed (%) Not Depressed 
(%) 
P-Value 

































































































Covariates Depressed (%) Not Depressed 
(%) 
P-Value 
















Table 4.3: Univariate Logistic Regression Analysis 




































































































































































































































Viral Load 1.00 1.00, 1,00 0.13 
























































UNIVARIATE ANALYSIS RESULTS 
Our study examined the association between sociodemographic, behavioral and clinical factors 
earlier identified by previous studies to be associated with depressive disorders/symptoms in 
PLWHA. This study examined the relationship between each independent variable on self-
reported baseline depressive symptoms using the univariate analysis approach. 
SOCIODEMOGRAPHIC VARIABLES AND SELF-REPORTED DEPRESSIVE SYMPTOMS 
I examined eight sociodemographic variables including: age, gender, ethnicity, marital status, 
employment status, formal and informal social support and available transportation. 
According to our univariate analysis, age was not significantly associated with self-reported 
depressive symptoms. However, we observed that the odds of reporting depressive symptoms 
decrease with increasing age.  
Gender did not significantly predict depressive symptoms among PLWHA in our study (P = 0.71). 
However, we observed that male PLWHA are 1.21 more likely to self-report depressive symptoms 
than female PLWHA OR 1.21 (95% CI: 0.44 – 3.30). 
Our results on ethnicity found indigenous ancestry to be negatively associated with self-reported 
depressive symptoms among our participants. Indigenous people are 75% less likely to self-report 
depressive symptoms when compared with Caucasians OR 0.25 (95% CI: 0.06 – 0.94). 
The association between marital status and self-reported depressive symptoms was marginally 
significant (P = 0.07). We found single, separated or divorced status to be protective against 







Being employed was an independent predictor of self-reported depressive symptoms (P = 0.03). 
Employed PLWHA are 4.4 times more likely to self-report depressive symptoms than it is for 
unemployed participants OR 4.40 (95% CI: 1.21 – 15.70). 
Formal social support independently predicts depressive symptoms (P = 0.04). PLWHA with 
consistent support from the government are 11.7 time more likely to self-report depressive 
symptoms when compared to participants without government assistance OR 11.70 (95% CI: 1.10 
– 124.80). Informal social support was not associated with self-reported depressive symptoms in 
our study (P = 0.42).  
Available transportation and informal social support were not statistically significant. This might 
be because the data had too many missing values. 
BEHAVIORAL VARIABLES AND SELF-REPORTED DEPRESSIVE SYMPTOMS 
Seven behavioral variables were examined including: men sex men (MSM), injection drug use 
(IDU), incarceration, smoking, marijuana use, cocaine use and alcohol consumption. 
MSM/homosexual practice was an independent predictor of self-reported depressive symptoms 
among our participants (P = 0.01). Homosexual men are 14 times more likely to self-report 
depressive symptoms when compared to heterosexual men 
OR= 14.0 (95% CI: 1.69 – 115.83).  
Prior incarceration history independently predicted self-reported depressive symptoms in our study 
(P = 0.02). PLWHA with prior incarceration history are 6.18 times more likely to report depressive 
symptoms than PLWHA without incarceration history OR= 6.18 (95% CI: 1.41 – 27.02). 
Alcohol consumption was found to be protective against depressive symptoms. Although the 






likely to self-report depressive symptoms when compared to those that denied alcohol 
consumption. 
Smoking, injection and non-injection drug, marijuana and cocaine use did not independently 
predict the odds of self-reporting depressive symptoms.  
CLINICAL VARIABLES AND SELF-REPORTED DEPRESSIVE SYMPTOMS 
We independently tested four clinical variables including: viral load, CD4 cell counts, AST and 
ALT liver enzymes. 
Blood viral load was not a significant predictor of depressive symptoms in our study (P = 0.13). 
The CD4 cell count was not associated with self-reporting depressive symptoms in our study. 
Although CD4 cell counts was not statistically significant, we observed the odds of self-reporting 
depressive symptoms to decrease as the blood CD4+ increases in our study. 
We did not find significant association between liver enzymes (AST&ALT) and self-reported 
depressive symptoms. Our results suggested that the odds of self-reporting depressive symptoms 
decrease as the liver enzymes blood counts increase. 
Table 4.4: Multivariate Logistic Regression Analysis 

































MULTIVARIATE ANALYSIS RESULTS 
Five variables from the univariate analysis independently predicted the odds of self-reporting 
depressive symptoms in our study. These were ethnicity, employment status, formal social support, 
MSM and incarceration. However, only MSM and employment status were significant at the level 
of multivariate analysis. 
Homosexual men are 17.1 times more likely to self-report depressive symptoms compared to 
heterosexual men after controlling for employment status OR 17.1 (95% CI: 1.12 – 44.50). 
Employed PLWHA are 7.04 times more likely to self-report depressive symptoms than 
unemployed individuals living with HIV/AIDS after controlling for homosexuality OR 7.04 (95% 
CI: 1.48 – 198.50). 







CHAPTER 5: DISCUSSION AND CONCLUSION 
 
In this study, we focused on the factors that are associated with self-reported depressive symptoms 
among three hundred and fifty-one seropositive patients that were accessing care at the PLP of the 
RUH in Saskatoon. We aimed to estimate the prevalence of depressive symptoms, and to identify 
those factors that would be associated with the odds of self-reporting depressive symptoms among 
our study participants. In this chapter, we summarize our findings, compare our results with 
previous studies and highlighted the study implications and some limitations in our study. 
PREVALENCE OF DEPRESSIVE SYMPTOMS 
Approximately one third (32.3%), 113 of 351 participants self-reported depressive symptoms and 
18 (5.1%) denied depressive symptoms. From the 113 patients that self-reported depressive 
symptoms, majority 90 (76.6%) were between 30 to 50 years of age, 68 (60%) male, 45 (40%) 
females, 49 (48.5%) self-identified as First Nation, Métis or Inuit, 45 (44.5%) Caucasian, 3 (2.97 
%) Black, and 4 (3.96%) were from other ethnicities.  
L’akoa et al. (2013) reported 63% rate of depressive symptoms among PLWHA in Yaoundé, 
Cameroon (L’akoa et al., 2013), Wang et al. (2018) observed 50.8% prevalence rate of depressive 
symptoms among Chinese individuals living with HIV/AIDS (Wang et al., 2018), and Choi et al. 
(2016) established a 28%  prevalence of depressive symptoms among 3,816 PLWHA in Ontario, 
Canada (Choi et al., 2016). The observed prevalence of depressive symptoms in our study (32.3%) 
is significantly lower than the studies of L’akoa et al. (2013) and Wang et al. (2018).  However, 
our observed prevalence lies within 0% to 47.8% global rate of depressive disorders (Ciesla and 






Our study did not explore specific factors that contributed to the high prevalence of depressive 
symptoms among our participants-variances might have resulted from the study design. 
SOCIO-DEMOGRAPHIC FACTORS AND DEPRESSIVE SYMPTOMS 
Socio-demographic variables (ethnicity, employment status and formal support) were significantly 
associated with self-reported depressive symptoms when examined independently. Indigenous 
PLWHA were 75% less likely to self-report depressive symptoms than Caucasians OR 0.25 (95% 
CI: 0.06 – 0.94). Also, employed PLWHA were 4.4 times more likely to self-report depressive 
symptoms than unemployed PLWHA OR 4.40 (95% CI: 1.21 – 15.70). 
Age – Liu et al. (2014) in Nanning, China, observed that older participants were more likely than 
younger participants to report depressive symptoms. The authors determined that older participants 
often experience problem keeping up with medical care and sometimes reduced social supports ( 
Liu et al., 2014). Anagnostopoulos et al. (2015) in Switzerland found that younger participants 
were more likely to self-report depressive symptoms compared to older participants 
(Anagnostopoulos et al., 2015). Choi et al. (2016) in Ontario also established that younger 
participants were more likely to report both incidence and  prevalence depressive symptoms when 
compared to older participants (Choi et al., 2016). Our results on age were contrary to the findings 
of Liu et al. (2014), Anagnostopoulos et al. (2015) and Choi et al. (2016), as we found no 
significant association between age and self-reported depressive symptoms. Our results did agree 
with the results of Rai and Verma. (2015) that found no significant association between age and 
depression among 104 PLWHA in India (Rai and Verma, 2015). 
Gender – Earlier study by Bhatia et al. (2011) in Houston, Texas established that female 
individuals living with HIV/AIDS were 5.71 more likely than male PLWHA to report major 






higher odds of depressive symptoms among female participants than it was for male participants 
OR 1.20 (95% CI: 1.02 – 1.40)(Choi et al., 2016). On the contrary, Mohammad et al. (2015) 
observed that male PLWHA were 1.6 times more likely than female PLWHA to self-report 
depression (Mohammed et al., 2015). Our results contradicted the studies of Bhatia and Munjal. 
(2014), Choi et al. (2016) and Mohammad et al. (2015), as we did not find a significant association 
between gender and self-reported depressive symptoms. However, our result was consistent with 
the findings of Rai and Verma. (2015 ) that did not find an association between gender and 
depression (Rai and Verma, 2015). 
Ethnicity – Earlier studies have observed higher rates of depressive disorders/symptoms among 
indigenous people and immigrants to a new environment (Cain et al., 2013; Wong et al., 2013; 
Chen et al., 2014). Perceived stigmatization, racism, social isolation and other psychosocial 
stressors confronting immigrants were highlighted to be responsible for the increased prevalence 
of depressive disorders/symptoms amongst them (Wong et al., 2013; Chen et al., 2014). Choi et 
al. (2016) in Ontario, Canada found no significant association between ethnocultural minorities 
and the incident of reporting depressive symptoms (Choi et al., 2016). Contrary to the results of 
Choi et al. (2016), our univariate analysis found patients that self-identified as First Nations, Inuit 
and Métis were 75% less likely than Caucasians to self-report depressive symptoms OR 0.25 (95% 
CI: 0.06 – 0.94). 
Indigenous ancestry was not a significant predictor in our multivariable model. Our results on 
ethnicity was based on 118 (33.6%) reported data. Most of the data was missing, resulting in 
unevenness in our variable (ethnicity) both across and within the group. Also, previous studies 
have observed that people with consistent social support (formal or informal) are less likely to 






(Vyavaharkar et al., 2010; Liu et al., 2013; Liu et al., 2014; Kingori et al., 2015;  Matsumoto et 
al., 2017; Thai et al., 2017). From our study, a majority (54.4%) of indigenous people had social 
support (formal or informal) as opposed to 33% of Caucasians that reportedly denied being on 
social support; this also could have been the reason why we found indigenous ancestry to be 
protective against self-reported depressive symptoms. 
Marital Status – Marital discord could increase the burden of depressive disorders/symptoms 
among married people  (Robles et al.,  2014). Rong et al. (2017) in Wuhan, China observed that  
married people/staying with a partner increases the odds of reporting depression by 2.40 when 
compared to single or never married PLWHA (Rong et al., 2017). Meanwhile, Egbe et al. (2017) 
in  Abuja, Nigeria determined that single people were 2.8 times more likely than married PLWHA 
to report a depressive episode (Egbe et al., 2017). Our study contradicted the studies of Rong et 
al. (2017) and Egbe et al. (2017), but consistent with the results of Rai and Verma. (2015) as we 
did not find a significant association between marital status and self-reported depressive 
symptoms. 
Employment – Being unemployed is an independent predictor of depressive disorders/symptoms 
in PLWHA (Bing et al., 2001; Su et al., 2013; Anagnostopoulos et al., 2015). Bhatia et al. (2011) 
observed that unemployed PLWHA are 1.54 times more likely than unemployed PLWHA to report 
depressive episodes (Bhatia et al., 2011). Nordenmark. (1999) observed the role of employment 
on self-perception, psychological wellness and social integration (Nordenmark, 1999). Contrarily, 
Maslach et al. (2001) determined that work related stress (burnout) such as role conflict, lack of 
autonomy and time pressure can increase the risk of depression among the employed population 
(Maslach et al., 2001). According to Maslach et al. (2001), “burnout encompasses a work-related 






cynicism and detachment from the job, and a sense of ineffectiveness and lack of accomplishment 
at work”. (Maslach et al., 2001).  
The results from our multivariate analysis showed that employed PLWHA are 7.04 more likely to 
self-report depressive symptoms than unemployed PLWHA OR 7.04 (95% CI: 1.48 – 198.50). 
Apart from high missing values (60.9%) that can bias our result, work related stress reinforced by 
the stress of coping with HIV infection could account for the high rate of depressive symptoms 
among employed PLWHA in our study. 
Social Support (Formal/Informal) – Earlier studies argued that consistent social support can help 
to reduce the burden of depressive disorders/symptoms in individuals living with HIV/AIDS 
(Vyavaharkar et al., 2010; Liu et al., 2013; Liu et al., 2014; Kingori et al., 2015; Thai et al., 2017; 
Matsumoto et al., 2017). Bekele et al. (2013) found that PLWHA with social support were less 
likely to feel depressed compared to those without social support (Bekele et al., 2013). Our result 
showed that formal support independently predicted the odds of reporting depressive symptoms 
OR 11.7 (95% CI: 1.10 – 124.80). Formal support was found not to be significant at the level of 
multivariable analysis. Although we did not know why our result on formal support contradicts 
the results from previous studies, we, however, attributed the conflicting findings to high numbers 
of missing data.  
BEHAVIORAL RISK FACTORS AND DEPRESSIVE SYMPTOMS 
Apart from MSM and incarceration, our study did not find any association between other 
behavioral factors being examined and self-reported depressive symptoms. 
Among the entire population, homosexual men are being discriminated against due to their sexual 
identity (Ahaneku et al., 2016). Also, their sexual orientation may limit the expression of 






in France determined that homosexual men are 5.1 times more likely than heterosexual men to 
report major depression (Feuillet et al., 2017). Scott et al. (2016) in Canada observed that 
homosexual men are 2.09 more likely than heterosexual men to report depressive symptoms (Scott 
et al., 2016). From our study, we determined that homosexual men (MSM) were 17.1 times more 
odds to self-report depressive symptoms than heterosexual men OR 17.1 (95% CI: 1.12 - 44.50). 
Also, we observed that prior history of incarceration was independently associated with the odds 
of reporting depressive symptoms OR 6.18 (95% CI: 1.41 - 27.02). Due to high numbers of missing 
values (71.7%), we did not consider this variable for our multivariate analysis. 
CLINICAL RISK FACTORS AND DEPRESSIVE SYMPTOMS 
This study did not find any significant association between clinical factors and depression in 
PLWHA. Our result on CD4 cell counts agrees with the study by Rai and Verma. (2015) India 
where the association between CD4 cell counts and depression among participants was not 
significant (Rai and Verma, 2015). 
STUDY LIMITATIONS 
Several limitations of this study should be noted. Firstly, as this is a cross-sectional study, causal 
relationships cannot be inferred based on the results. The self-reported nature of our outcome 
variable (depressive symptoms) was prone to information bias. Secondly, based on the method of 
recruiting the patients to the PLP care center, our results would be prone to selection bias which 
can affect the generalizability of our findings. Finally, many of our variables are missing and 







Despite the study limitations highlighted above, the study also had several strengths. First, our 
study is the first of its kind to examine the influence of socio-demographic, behavioural and clinical 
variables on the relationship between HIV and depression among PLWHA in Saskatoon. This 
study is important because prior studies have excluded, ignored or controlled for the impact of 
clinical variables such as CD4+ cell counts, viral load and liver function test from their explanatory 
models for the relationship between HIV and depression among PLWHA and does not mirror 
reality.  
The evidence showed by this study for employed and MSM patients is critical for future research. 
This study also contributes significantly to the evidence based on the relationship between 
depression and HIV among PLWHA due to the paucity of information in this research area, 
especially in Saskatchewan. 
CONCLUSIONS 
Aside from the varying rates of the prevalence of depressive disorders/symptoms reported in 
PLWHA in developed and developing countries, the relationship between depressive symptoms 
and PLWHA have not been extensively researched. Differences in measuring instruments, study 
timeframe, location and study population make it impractical to have a unified rate of depressive 
disorders/symptoms in PLWHA. Also, there have been several equivocal results or opinions from 
prior studies on the impact of examined risk factors on the association between depressive 
disorders/symptoms and PLWHA. Particularly neglected in prior research is the impact of clinical 
factors, which was thoroughly examined in this thesis but was not associated with depressive 







Based on this study, we observed that indigenous ancestry, employed, formal social support, men 
who have sex with men (MSM)/homosexual men and those with history of incarceration were 
independently associated with self-reported baseline depressive symptoms in unadjusted models. 
However, MSM and employed PLWHA were significantly associated with self-reported baseline 
depressive symptoms in PLWHA at the level of the multivariate logistic model. Therefore, future 
social programs targeting homosexual men and employed PLWHA should be developed to 
manage early signs and symptoms of depression among these vulnerable populations in Saskatoon. 
For future research, we suggest the use of a standardized means of diagnosing depression among 
PLWHA. A unified approach to the diagnosis of depression will reduce the potential for 
information and misclassification bias in the data. Researchers and healthcare providers should 
employ multiple ways to ensure completeness of participant data to improve the precision of the 
study estimate. Adequate staff training, telephone reminders and patient-tracking tools can be used 
to improve the documentation in resource-limited settings, especially on clinical risk factors in 
patient charts. Overall, the use of electronic medical records is a viable option to increase the study 
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Socio-demographic Variables VIF 
Variables Tolerance Variance Inflated Factor 
Age .283 3.535 
Sex 0.040 25.241 
Ethnicity 0.045 22.336 
Marital Status 0.201 4.977 
Employment Status 0.289 3.462 
Formal Social Support 0.228 4.387 
Available Housing 0.660 1.515 










Behavioural Risk Factors VIF 
Variables Tolerance Variance Inflation Factor 
MSM 0.36 2.79 
IDU 0.47 2.12 
Incarceration 0.74 1.35 
Smoking 0.53 1.90 
Marijuana Use 0.79 1.36 
Alcohol Consumption 0.65 1.54 










Clinical Risk Factors VIF 
Variables Tolerance Variance Inflation Factor 
Viral Load 0.87 1.15 
CD4+ 0.80 1.25 
AST 0.42 2.40 
ALT 0.38 2.64 
GGT 0.64 1.57 
ALP 0.84 1.19 





















































































                                                                                                                                                                                               
